Annual D&A
$203.00 K
-$280.00 K-57.97%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual depreciation & amortization is $203.00 thousand, with the most recent change of -$280.00 thousand (-57.97%) on December 1, 2023.
- During the last 3 years, NBY annual D&A has risen by +$152.00 thousand (+298.04%).
- NBY annual D&A is now -57.97% below its all-time high of $483.00 thousand, reached on December 31, 2022.
Performance
NBY Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$95.00 K
-$84.00 K-46.93%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly depreciation & amortization is $95.00 thousand, with the most recent change of -$84.00 thousand (-46.93%) on September 1, 2024.
- Over the past year, NBY quarterly D&A has stayed the same.
- NBY quarterly D&A is now -46.93% below its all-time high of $179.00 thousand, reached on June 1, 2024.
Performance
NBY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$228.00 K
$0.000.00%
September 1, 2024
Summary
- As of February 7, 2025, NBY TTM depreciation & amortization is $228.00 thousand, unchanged on September 1, 2024.
- Over the past year, NBY TTM D&A has dropped by -$156.00 thousand (-40.62%).
- NBY TTM D&A is now -52.80% below its all-time high of $483.00 thousand, reached on December 31, 2022.
Performance
NBY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
NBY Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.0% | 0.0% | -40.6% |
| 3 y3 years | +298.0% | -37.9% | -44.1% |
| 5 y5 years | -23.7% | -37.9% | -44.1% |
NBY Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.0% | +70.6% | -46.9% | +263.8% | -52.8% | +91.6% |
| 5 y | 5-year | -58.0% | +298.0% | -46.9% | +263.8% | -52.8% | +430.2% |
| alltime | all time | -58.0% | +322.9% | -46.9% | +263.8% | -52.8% | +570.6% |
NovaBay Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $95.00 K(-46.9%) | $228.00 K(0.0%) |
| Jun 2024 | - | $179.00 K(+1391.7%) | $228.00 K(+12.9%) |
| Mar 2024 | - | $12.00 K(-120.7%) | $202.00 K(-0.5%) |
| Dec 2023 | $203.00 K(-58.0%) | -$58.00 K(-161.1%) | $203.00 K(-47.1%) |
| Sep 2023 | - | $95.00 K(-37.9%) | $384.00 K(-5.9%) |
| Jun 2023 | - | $153.00 K(+1076.9%) | $408.00 K(+8.8%) |
| Mar 2023 | - | $13.00 K(-89.4%) | $375.00 K(-22.4%) |
| Dec 2022 | $483.00 K(+305.9%) | $123.00 K(+3.4%) | $483.00 K(+8.1%) |
| Sep 2022 | - | $119.00 K(-0.8%) | $447.00 K(+31.5%) |
| Jun 2022 | - | $120.00 K(-0.8%) | $340.00 K(+47.2%) |
| Mar 2022 | - | $121.00 K(+39.1%) | $231.00 K(+94.1%) |
| Dec 2021 | $119.00 K(+133.3%) | $87.00 K(+625.0%) | $119.00 K(+176.7%) |
| Sep 2021 | - | $12.00 K(+9.1%) | $43.00 K(0.0%) |
| Jun 2021 | - | $11.00 K(+22.2%) | $43.00 K(-6.5%) |
| Mar 2021 | - | $9000.00(-18.2%) | $46.00 K(-9.8%) |
| Dec 2020 | $51.00 K(-21.5%) | $11.00 K(-8.3%) | $51.00 K(-7.3%) |
| Sep 2020 | - | $12.00 K(-14.3%) | $55.00 K(-8.3%) |
| Jun 2020 | - | $14.00 K(0.0%) | $60.00 K(-3.2%) |
| Mar 2020 | - | $14.00 K(-6.7%) | $62.00 K(-4.6%) |
| Dec 2019 | $65.00 K(-75.6%) | $15.00 K(-11.8%) | $65.00 K(-33.0%) |
| Sep 2019 | - | $17.00 K(+6.3%) | $97.00 K(-43.6%) |
| Jun 2019 | - | $16.00 K(-5.9%) | $172.00 K(-28.9%) |
| Mar 2019 | - | $17.00 K(-63.8%) | $242.00 K(-9.0%) |
| Dec 2018 | $266.00 K(+180.0%) | $47.00 K(-48.9%) | $266.00 K(+2.3%) |
| Sep 2018 | - | $92.00 K(+7.0%) | $260.00 K(+39.8%) |
| Jun 2018 | - | $86.00 K(+109.8%) | $186.00 K(+57.6%) |
| Mar 2018 | - | $41.00 K(0.0%) | $118.00 K(+24.2%) |
| Dec 2017 | $95.00 K(-16.7%) | $41.00 K(+127.8%) | $95.00 K(+35.7%) |
| Sep 2017 | - | $18.00 K(0.0%) | $70.00 K(-15.7%) |
| Jun 2017 | - | $18.00 K(0.0%) | $83.00 K(-9.8%) |
| Mar 2017 | - | $18.00 K(+12.5%) | $92.00 K(-19.3%) |
| Dec 2016 | $114.00 K(-30.5%) | $16.00 K(-48.4%) | $114.00 K(-18.0%) |
| Sep 2016 | - | $31.00 K(+14.8%) | $139.00 K(-6.7%) |
| Jun 2016 | - | $27.00 K(-32.5%) | $149.00 K(-8.6%) |
| Mar 2016 | - | $40.00 K(-2.4%) | $163.00 K(-0.6%) |
| Dec 2015 | $164.00 K | $41.00 K(0.0%) | $164.00 K(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $41.00 K(0.0%) | $170.00 K(-1.7%) |
| Jun 2015 | - | $41.00 K(0.0%) | $173.00 K(-14.8%) |
| Mar 2015 | - | $41.00 K(-12.8%) | $203.00 K(-12.5%) |
| Dec 2014 | $232.00 K(-26.1%) | $47.00 K(+6.8%) | $232.00 K(-10.4%) |
| Sep 2014 | - | $44.00 K(-38.0%) | $259.00 K(-11.9%) |
| Jun 2014 | - | $71.00 K(+1.4%) | $294.00 K(-3.0%) |
| Mar 2014 | - | $70.00 K(-5.4%) | $303.00 K(-3.5%) |
| Dec 2013 | $314.00 K(-7.9%) | $74.00 K(-6.3%) | $314.00 K(-3.4%) |
| Sep 2013 | - | $79.00 K(-1.3%) | $325.00 K(-0.9%) |
| Jun 2013 | - | $80.00 K(-1.2%) | $328.00 K(-0.9%) |
| Mar 2013 | - | $81.00 K(-4.7%) | $331.00 K(-2.9%) |
| Dec 2012 | $341.00 K(-19.8%) | $85.00 K(+3.7%) | $341.00 K(-5.3%) |
| Sep 2012 | - | $82.00 K(-1.2%) | $360.00 K(-6.0%) |
| Jun 2012 | - | $83.00 K(-8.8%) | $383.00 K(-6.4%) |
| Mar 2012 | - | $91.00 K(-12.5%) | $409.00 K(-3.8%) |
| Dec 2011 | $425.00 K(-0.5%) | $104.00 K(-1.0%) | $425.00 K(-0.9%) |
| Sep 2011 | - | $105.00 K(-3.7%) | $429.00 K(-0.2%) |
| Jun 2011 | - | $109.00 K(+1.9%) | $430.00 K(+0.5%) |
| Mar 2011 | - | $107.00 K(-0.9%) | $428.00 K(+0.2%) |
| Dec 2010 | $427.00 K(+14.5%) | $108.00 K(+1.9%) | $427.00 K(+0.7%) |
| Sep 2010 | - | $106.00 K(-0.9%) | $424.00 K(+2.4%) |
| Jun 2010 | - | $107.00 K(+0.9%) | $414.00 K(+4.8%) |
| Mar 2010 | - | $106.00 K(+1.0%) | $395.00 K(+5.9%) |
| Dec 2009 | $373.00 K(+22.7%) | $105.00 K(+9.4%) | $373.00 K(+6.6%) |
| Sep 2009 | - | $96.00 K(+9.1%) | $350.00 K(+5.1%) |
| Jun 2009 | - | $88.00 K(+4.8%) | $333.00 K(+3.7%) |
| Mar 2009 | - | $84.00 K(+2.4%) | $321.00 K(+5.6%) |
| Dec 2008 | $304.00 K(+66.1%) | $82.00 K(+3.8%) | $304.00 K(+9.7%) |
| Sep 2008 | - | $79.00 K(+3.9%) | $277.00 K(+12.6%) |
| Jun 2008 | - | $76.00 K(+13.4%) | $246.00 K(+13.9%) |
| Mar 2008 | - | $67.00 K(+21.8%) | $216.00 K(+18.0%) |
| Dec 2007 | $183.00 K(+147.3%) | $55.00 K(+14.6%) | $183.00 K(+43.0%) |
| Sep 2007 | - | $48.00 K(+4.3%) | $128.00 K(+60.0%) |
| Jun 2007 | - | $46.00 K(+35.3%) | $80.00 K(+135.3%) |
| Mar 2007 | - | $34.00 K | $34.00 K |
| Dec 2006 | $74.00 K(+54.2%) | - | - |
| Dec 2005 | $48.00 K | - | - |
FAQ
- What is NovaBay Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual D&A year-on-year change?
- What is NovaBay Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly D&A year-on-year change?
- What is NovaBay Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals TTM D&A year-on-year change?
What is NovaBay Pharmaceuticals annual depreciation & amortization?
The current annual D&A of NBY is $203.00 K
What is the all time high annual D&A for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual depreciation & amortization is $483.00 K
What is NovaBay Pharmaceuticals annual D&A year-on-year change?
Over the past year, NBY annual depreciation & amortization has changed by -$280.00 K (-57.97%)
What is NovaBay Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of NBY is $95.00 K
What is the all time high quarterly D&A for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly depreciation & amortization is $179.00 K
What is NovaBay Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, NBY quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is NovaBay Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of NBY is $228.00 K
What is the all time high TTM D&A for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high TTM depreciation & amortization is $483.00 K
What is NovaBay Pharmaceuticals TTM D&A year-on-year change?
Over the past year, NBY TTM depreciation & amortization has changed by -$156.00 K (-40.62%)